Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SENP2 | Q9HC62 | 5/20 | 0.44 |
| ▸ | SENP1 | Q9P0U3 | 4/20 | 0.44 |
| ▸ | SUMO2 | P61956 | 4/20 | 0.44 |
| ▸ | SUMO1 | P63165 | 4/20 | 0.44 |
| ▸ | SENP7 | Q9BQF6 | 4/20 | 0.44 |
| ▸ | SENP3 | Q9H4L4 | 2/20 | 0.44 |
| ▸ | MYC | P01106 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.39 |
| ▸ | MPL | P40238 | 5/20 | 0.39 |
| ▸ | TTR | P02766 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.36 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.36 |
| ▸ | ATIC | P31939 | 2/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30218697 | 1.00 | SENP2 (0.44) | SENP2SENP1SUMO2SUMO1SENP7 | |
| SCHEMBL14219569 | 0.85 | SENP2 (0.51) | SENP2SENP1SUMO2SUMO1SENP7 | |
| SCHEMBL15851424 | 0.84 | CYP1A2 (0.40) | SENP2SENP1SUMO2SUMO1SENP7 | |
| SCHEMBL30218704 | 0.79 | CYP1A2 (0.48) | SENP2SENP1SUMO2SUMO1SENP7 | |
| SCHEMBL18936308 | 0.79 | CYP1A2 (0.48) | SENP2SENP1SUMO2SUMO1SENP7 | |
| SCHEMBL2662857 | 0.76 | CYP1A2 (0.54) | SENP2SENP1SUMO2SUMO1SENP7 | |
| SCHEMBL2624859 | 0.76 | MPL (0.57) | SENP2SENP1SUMO2SUMO1SENP7 | |
| SCHEMBL13460242 | 0.76 | LMNA (0.55) | SENP2SENP1SUMO2SUMO1SENP7 | |
| SCHEMBL18937495 | 0.74 | SENP2 (0.56) | SENP2SENP1SUMO2SUMO1SENP7 | |
| SCHEMBL18078576 | 0.74 | SENP2 (0.64) | SENP2SENP1SUMO2SUMO1SENP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108699003-B | Catalytic hydrogenation process for preparing pyrazoles | 巴斯夫欧洲公司 | 2023-02-03 | — | — | CN | disclosed |
| US-10975036-B2 | Catalytic hydrogenation process for preparing pyrazoles | BASF SE (DE) | 2021-04-13 | — | — | US | disclosed |
| EP-3411360-B1 | CATALYTIC HYDROGENATION PROCESS FOR PREPARING PYRAZOLES | BASF SE (DE) | 2020-03-11 | — | — | EP | disclosed |
| US-20190055200-A1 | Catalytic Hydrogenation Process for Preparing Pyrazoles | BASF SE (DE) | 2019-02-21 | — | — | US | disclosed |
| CN-108699003-A | Prepare the catalytic hydrogenation of pyrazoles | 巴斯夫欧洲公司 | 2018-10-23 | — | — | CN | disclosed |
| EP-3178813-A1 | METHOD FOR PREPARING HALOGENATED 3-OXOCARBOXYLATES CARRYING A 2-ALKOXYMETHYLIDENE OR A 2-DIALKYLAMINOMETHYLIDENE GROUP | BASF SE (DE) | 2017-06-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190055200-A1 | Catalytic Hydrogenation Process for Preparing Pyrazoles | HRH2, HPD, HRAS | SENP2 2334/4885SENP1 1550/4885SUMO2 2819/4885 |
| US-10975036-B2 | Catalytic hydrogenation process for preparing pyrazoles | HRH2, HVCN1, LBR | SENP2 2755/4885SENP1 2181/4885SUMO2 3700/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.